- Fee assured
- Verified this account
Professor Brunt has an international reputation for the oncological management of breast cancer as a leading clinical researcher
Areas of interest
Skin tumours / cancer/ oncology; Palliative care; Breast oncology, radiotherapy, chemotherapy, hormone therapy, targeted therapy; Clinical trials; Dupuytren's - radiotherapy
Current NHS consultant posts held
University Hospital of North Staffordshire and Keele University, Stoke-on-Trent
Breast cancer trials of targeted therapy, radiotherapy, chemotherapy, hormone therapy and vaccine therapy.
- MB BS London University (Westminster) 1983
- MRCP Royal College of Physicians 1986
- FRCR Royal College of Radiologists 1990
- FRCP Royal College of Physicians 2008
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
Information for healthcare professionals (Bupa patients only, last 12 months)
Clinical supervision and planning for delivery of chemotherapy cycle 1 - 21 days - (>50)
Clinical supervision and planning for delivery of chemotherapy cycle in the member's home 1-21 days - (5-50)
Clinical supervision and planning for delivery of chemotherapy cycle 1 - 28 days - (5-50)
Clinical supervision of external beam radiotherapy, up to and including 15 fractions or part thereof - (5-50)
Preparation for superficial radiotherapy with imaging, dosimetry and calculation - (1-5)
- Show All (7)...